Given the association between QT interval prolongation, reduced EF, coronary artery disease (CAD), and inflammation, and given the inflammatory characteristics of a high plasma FABP3 level and its relationship with CVD, we hypothesized that FABP3 may be a surrogate marker independently associated with QTc interval prolongation and reduced EF in humans. The gene discussed is FABP3; the disease is coronary artery disorder.